medical Class II Updated 2024-02-14

Becton Dickinson & Co. recalls BD BBL Sensi Disc Rifampin- 5 ug, used for semi-quantitative

Recalled Product

BD BBL Sensi Disc Rifampin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231541 and 231544¿


Hazard / Issue

There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.

Issued by

FDA

Distribution: Nationwide (United States)
Lot/Code Info: Catalog No. 231541 UDI-DI 00382902315414 Lots 1278110 1334479 2004554 2025125 2056466 2242510 3214931; Catalog No. 231544¿ UDI-DI 30382902315446 Lots 1116055 1211489 2339407 3030278 3158059 3214931 0343413 1032232 1088790 1148547 1278110 1334479 2004554 2025125 2056466 2090443 2242510
View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon →